Neomycin Creams And Ointments Suppliers & Bulk Manufacturers
Available Forms: Topical Creams and Ointments
Available Strengths: 0.5% or 1%
Reference Brands: Neosporin(US & EU)
Category:
Antibiotics
Neomycin creams and ointments inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing bacterial growth and causing cell death. They effectively treat superficial skin and mucous membrane infections, offering rapid, targeted relief with minimal systemic absorption, making them reliable for first-line bacterial skin infection management.
Neomycin Creams and Ointments is available in Topical Creams and Ointments
and strengths such as 0.5% or 1%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Neomycin Creams and Ointments is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Neomycin Creams and Ointments can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Neomycin creams and ointments are approved in the EU and US for topical bacterial infections, including skin and mucous membrane infections. In the EU, brands like Neosporin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on clinical data; generic products are available. Both regions require detailed dossiers, including clinical trial results, quality standards, and pharmacovigilance plans for approval and safety monitoring. For regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for neomycin topical formulations, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing